Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “TURNING POINT THERAPEUTICS, INC.”

15 pharma patents match "TURNING POINT THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 15
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 15 pharmaceutical patents matching "TURNING POINT THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

15 results for “TURNING POINT THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12310968

    Chiral diaryl macrocycles and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  2. US 12187739

    Diaryl macrocycle polymorph

    TURNING POINT THERAPEUTICS, INC. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  3. US 11981684

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted May 14, 2024 · Expires May 9, 2044

    granted
  4. US 11666574

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  5. US 11654145

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  6. US 11634433

    Macrocycles for use in treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  7. US 11452725

    Chiral diaryl macrocycles and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  8. US 11291667

    Combination therapy involving diaryl macrocyclic compounds

    TURNING POINT THERAPEUTICS, INC. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  9. US 11286264

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  10. US 11286265

    Macrocyclic compounds for treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  11. US 11155563

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  12. US 11142533

    Macrocycles for use in treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  13. US 11008337

    Chiral diaryl macrocycles as modulators of protein kinases

    TURNING POINT THERAPEUTICS, INC. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  14. US 10745416

    Macrocyclic compounds for treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted
  15. US 10689400

    Macrocycle kinase inhibitors

    TURNING POINT THERAPEUTICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted